Cohen P L
Clin Exp Immunol. 1980 May;40(2):365-72.
As has been found for spleen cells from ageing NZB x NZW (B/W) mice, ageing NZB mice were also found to make no antibody when stimulated in vitro with the polyclonal B cell activators (PBA) LPS and PPD. This immune defect was not due to the action of suppressor cells, since old NZB and B/W spleen cells did not suppress the PBA response of young spleen cells. Spleen cells from aged NZB mice were not able to generate antibody-forming cells when stimulated with the thymus-independent antigen, TNP-LPS, but were able to produce antibody in response to another thymus-independent antigen, TNP-AECM-Ficoll, thereby implying that there is a selective functional deletion of a B cell subpopulation in ageing New Zealand mice. The failure of B/W and NZB spleen cells to generate antibody in response to PBA is interpreted as a consequence of a continuing in vivo polyclonal B cell activation accompanying the development of autoimmune disease, leading to a scarcity of B cells available for activation by PBA and by some thymus-independent antigens in vitro.
正如在衰老的NZB x NZW(B/W)小鼠的脾细胞中所发现的那样,衰老的NZB小鼠在体外用多克隆B细胞激活剂(PBA)脂多糖(LPS)和结核菌素纯蛋白衍生物(PPD)刺激时也不产生抗体。这种免疫缺陷不是由于抑制细胞的作用,因为老龄NZB和B/W脾细胞不会抑制年轻脾细胞的PBA反应。衰老NZB小鼠的脾细胞在用非胸腺依赖性抗原TNP-LPS刺激时不能产生抗体形成细胞,但能对另一种非胸腺依赖性抗原TNP-AECM-菲可产生抗体,从而意味着在衰老的新西兰小鼠中存在B细胞亚群的选择性功能缺失。B/W和NZB脾细胞对PBA不产生抗体的现象被解释为是自身免疫性疾病发展过程中体内持续多克隆B细胞激活的结果,导致体外可被PBA和某些非胸腺依赖性抗原激活的B细胞数量稀少。